QIAGEN N.V. (QGEN) Stock Fundamental Analysis
NYSE:QGEN - New York Stock Exchange, Inc. - NL0015002CX3 - Common Stock - Currency: USD
Overall QGEN gets a fundamental rating of 6 out of 10. We evaluated QGEN against 56 industry peers in the Life Sciences Tools & Services industry. QGEN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QGEN is not valued too expensively and it also shows a decent growth rate. These ratings would make QGEN suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year QGEN was profitable.
In the past year QGEN had a positive cash flow from operations.
Each year in the past 5 years QGEN has been profitable.
In the past 5 years QGEN always reported a positive cash flow from operatings.
1.2 Ratios
QGEN's Return On Assets of 1.47% is fine compared to the rest of the industry. QGEN outperforms 73.21% of its industry peers.
QGEN has a Return On Equity of 2.34%. This is in the better half of the industry: QGEN outperforms 71.43% of its industry peers.
QGEN's Return On Invested Capital of 7.14% is fine compared to the rest of the industry. QGEN outperforms 76.79% of its industry peers.
QGEN had an Average Return On Invested Capital over the past 3 years of 7.25%. This is significantly below the industry average of 12.97%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROIC | 7.14% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
Looking at the Profit Margin, with a value of 4.23%, QGEN is in the better half of the industry, outperforming 73.21% of the companies in the same industry.
QGEN's Profit Margin has declined in the last couple of years.
QGEN has a better Operating Margin (25.02%) than 94.64% of its industry peers.
QGEN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 63.82%, QGEN belongs to the top of the industry, outperforming 91.07% of the companies in the same industry.
In the last couple of years the Gross Margin of QGEN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
QGEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, QGEN has less shares outstanding
QGEN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, QGEN has an improved debt to assets ratio.
2.2 Solvency
QGEN has an Altman-Z score of 4.12. This indicates that QGEN is financially healthy and has little risk of bankruptcy at the moment.
QGEN's Altman-Z score of 4.12 is amongst the best of the industry. QGEN outperforms 80.36% of its industry peers.
QGEN has a debt to FCF ratio of 2.77. This is a good value and a sign of high solvency as QGEN would need 2.77 years to pay back of all of its debts.
The Debt to FCF ratio of QGEN (2.77) is better than 80.36% of its industry peers.
QGEN has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of QGEN (0.38) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Altman-Z | 4.12 |
ROIC/WACC0.91
WACC7.88%
2.3 Liquidity
A Current Ratio of 3.61 indicates that QGEN has no problem at all paying its short term obligations.
QGEN's Current ratio of 3.61 is in line compared to the rest of the industry. QGEN outperforms 57.14% of its industry peers.
QGEN has a Quick Ratio of 3.09. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
QGEN has a Quick ratio of 3.09. This is comparable to the rest of the industry: QGEN outperforms 58.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
QGEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.95%, which is quite good.
The Earnings Per Share has been growing by 8.25% on average over the past years. This is quite good.
Looking at the last year, QGEN shows a small growth in Revenue. The Revenue has grown by 0.66% in the last year.
Measured over the past years, QGEN shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
3.2 Future
QGEN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.51% yearly.
The Revenue is expected to grow by 8.27% on average over the next years. This is quite good.
EPS Next Y8.07%
EPS Next 2Y8.28%
EPS Next 3Y9%
EPS Next 5Y7.51%
Revenue Next Year4.01%
Revenue Next 2Y5.05%
Revenue Next 3Y5.62%
Revenue Next 5Y8.27%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.40, QGEN is valued on the expensive side.
80.36% of the companies in the same industry are more expensive than QGEN, based on the Price/Earnings ratio.
QGEN is valuated rather cheaply when we compare the Price/Earnings ratio to 25.91, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.36, QGEN is valued correctly.
82.14% of the companies in the same industry are more expensive than QGEN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.85, QGEN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.4 | ||
| Fwd PE | 16.36 |
4.2 Price Multiples
87.50% of the companies in the same industry are more expensive than QGEN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, QGEN is valued cheaply inside the industry as 83.93% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.21 | ||
| EV/EBITDA | 12.74 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QGEN does not grow enough to justify the current Price/Earnings ratio.
QGEN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.28
PEG (5Y)2.23
EPS Next 2Y8.28%
EPS Next 3Y9%
5. Dividend
5.1 Amount
QGEN has a yearly dividend return of 0.59%, which is pretty low.
Compared to an average industry Dividend Yield of 0.53, QGEN pays a better dividend. On top of this QGEN pays more dividend than 94.64% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, QGEN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.59% |
5.2 History
QGEN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.28%
EPS Next 3Y9%
42.32
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners63.64%
Inst Owner Change-94.07%
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap9.15B
Analysts76
Price Target50.15 (18.5%)
Short Float %2.38%
Short Ratio3.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.59% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.23%
Min EPS beat(2)-3.85%
Max EPS beat(2)3.38%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-3.85%
Max EPS beat(4)3.38%
EPS beat(8)5
Avg EPS beat(8)1.25%
EPS beat(12)9
Avg EPS beat(12)4.32%
EPS beat(16)13
Avg EPS beat(16)5.2%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.02%
Revenue beat(8)0
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.75%
PT rev (1m)-1.18%
PT rev (3m)-3.34%
EPS NQ rev (1m)0.9%
EPS NQ rev (3m)1.16%
EPS NY rev (1m)2.06%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)1.3%
Revenue NY rev (3m)-1.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.4 | ||
| Fwd PE | 16.36 | ||
| P/S | 4.62 | ||
| P/FCF | 18.21 | ||
| P/OCF | 13.58 | ||
| P/B | 2.56 | ||
| P/tB | 10.91 | ||
| EV/EBITDA | 12.74 |
EPS(TTM)2.3
EY5.43%
EPS(NY)2.59
Fwd EY6.11%
FCF(TTM)2.32
FCFY5.49%
OCF(TTM)3.12
OCFY7.36%
SpS9.15
BVpS16.51
TBVpS3.88
PEG (NY)2.28
PEG (5Y)2.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROCE | 9.62% | ||
| ROIC | 7.14% | ||
| ROICexc | 9.2% | ||
| ROICexgc | 29.06% | ||
| OM | 25.02% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.82% | ||
| FCFM | 25.39% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Debt/EBITDA | 1.92 | ||
| Cap/Depr | 84.24% | ||
| Cap/Sales | 8.66% | ||
| Interest Coverage | 20.47 | ||
| Cash Conversion | 96.47% | ||
| Profit Quality | 600.91% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z | 4.12 |
F-Score7
WACC7.88%
ROIC/WACC0.91
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.95%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%19.57%
EPS Next Y8.07%
EPS Next 2Y8.28%
EPS Next 3Y9%
EPS Next 5Y7.51%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%5.37%
Revenue Next Year4.01%
Revenue Next 2Y5.05%
Revenue Next 3Y5.62%
Revenue Next 5Y8.27%
EBIT growth 1Y11.16%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year56.47%
EBIT Next 3Y22.36%
EBIT Next 5Y16.09%
FCF growth 1Y69.33%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y46.6%
OCF growth 3Y1.77%
OCF growth 5Y15.28%